ArticleMolecules (Basel, Switzerland)2022

Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity-In Vitro and In Vivo Studies.

Gniewomir Latacz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.